Закрите Акціонерне Товариство "Фармацевтична Фірма "Дарниця"
Закрытое акционерное общество "ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ДАРНИЦА"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрите Акціонерне Товариство "Фармацевтична Фірма "Дарниця", Закрытое акционерное общество "ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ДАРНИЦА"filedCriticalЗакрите Акціонерне Товариство "Фармацевтична Фірма "Дарниця"
Priority to UA98084342ApriorityCriticalpatent/UA32939A/en
Publication of UA32939ApublicationCriticalpatent/UA32939A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to the pharmaceutical industry. The composition contains sulfocamphoric acid, Novocain base, and the water for injections. 1
UA98084342A1998-08-101998-08-10Sulfocamphocain, method for its manufacture, and preparation of equipment for manufacturing sulfocamphocain
UA32939A
(en)
Stable polymorph of n-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy)-4- quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as metalloproteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
Pharmaceutical use of two isomerous derivatives of tetrahydrofuranics:tetrahudro-n,n-dimethyl-5,5-diphenyl-3-furanomethanamine (ae14) and tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanomethanamine (ae37)